These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4986099)

  • 1. Urinary and faecal iron excretion in thalassaemia syndromes.
    Malamos B; Constantoulakis M; Gyftaki E; Kesse-Elias M; Augoustaki O
    Acta Haematol; 1969; 42(6):321-9. PubMed ID: 4986099
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioactive iron (59Fe) excretion through the urine and feces after intravenous iron-59 administration in congenital hemolytic anemias.
    Gyftaki H; Kesse-Elias M; Constantoulakis M; Malamos B
    J Nucl Med; 1967 May; 8(5):385. PubMed ID: 6032706
    [No Abstract]   [Full Text] [Related]  

  • 3. Body iron excretion in man: a collaborative study.
    Green R; Charlton R; Seftel H; Bothwell T; Mayet F; Adams B; Finch C; Layrisse M
    Am J Med; 1968 Sep; 45(3):336-53. PubMed ID: 5672736
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro synthesis of haemoglobin from Fe59 and leucine-C14 by normal, sickle-cell and thalassaemic immature red cells.
    Malamos B; Gyftaki E; Elias-Kesse M; Christakopoulos P
    Acta Haematol; 1967; 38(4):200-8. PubMed ID: 4964888
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the mechanisms and sites of action of desferrioxamine in thalassaemia major.
    Bianco I; Graziani B; Lerone M; Congedo P; Clemente GF; Ingrao G; Ciccone F; Di Nucci GD; Mandelli F; Isacchi G
    Acta Haematol; 1984; 71(2):100-5. PubMed ID: 6421046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E; Bianco I; Graziani B; Lerone M; Valente M; Congedo P; Ponzini D; Costantini S
    Acta Haematol; 1982; 68(2):115-23. PubMed ID: 6812366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The iron status of Italian subjects with beta-thalassemia trait.
    Fargion S; Taddei MT; Cappellini MD; Piperno A; Fiorelli G
    Acta Haematol; 1982; 68(2):109-14. PubMed ID: 6812365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequacy of iron supply for erythropoiesis: in vivo observations in humans.
    Cazzola M; Pootrakul P; Bergamaschi G; Huebers HA; Eng M; Finch CA
    J Lab Clin Med; 1987 Dec; 110(6):734-9. PubMed ID: 3681115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project.
    Badawy SM; Payne AB; Hulihan MM; Coates TD; Majumdar S; Smith D; Thompson AA
    Br J Haematol; 2021 Dec; 195(5):e160-e164. PubMed ID: 34431082
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron absorption and excretion in experimental iron deficiency.
    Bannerman RM
    Nucl Med (Stuttg); 1963; 2():Suppl 1:77-80. PubMed ID: 5005239
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid diagnosis of iron deficiency by measurement of free erythrocyte porphyrins and hemoglobin: the FEP/hemoglobin ratio.
    Piomelli S; Brickman A; Carlos E
    Pediatrics; 1976 Jan; 57(1):136-41. PubMed ID: 1246489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron in sickle cell disease.
    Mehta BC; Mehta J
    J Assoc Physicians India; 1992 Feb; 40(2):133. PubMed ID: 1463501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
    Krüger N; Kijewski H; König R; Tillmann W; Schröter W
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods designed to measure transferrin and iron-binding capacity of serum.
    Burrows S
    Am J Clin Pathol; 1967 Mar; 47(3):326-8. PubMed ID: 4959980
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major.
    Noetzli LJ; Coates TD; Wood JC
    Br J Haematol; 2011 Jan; 152(2):229-33. PubMed ID: 21118197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
    Walter PB; Fung EB; Killilea DW; Jiang Q; Hudes M; Madden J; Porter J; Evans P; Vichinsky E; Harmatz P
    Br J Haematol; 2006 Oct; 135(2):254-63. PubMed ID: 17010049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution pattern of radioactive ferrioxamine administered intravenously in rats. I.
    Bobeck-Rutsaert MM; Wiltink WF; Op den Kelder AM; van Euk HG; Leijnse B
    Acta Haematol; 1972; 48(2):125-8. PubMed ID: 4628169
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
    Kirimlidis S; Philippidis P; Drossos C; Economidis J
    Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythrocyte enzymes in thalassaemia and thalassodrepanocytosis.
    Belfiore F; Meldolesi J; Calcara G
    Acta Haematol; 1965 Dec; 34(6):329-37. PubMed ID: 4956509
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iron excretion by gallbladder and small intestine].
    Dischler W; Okazaki T; Hoffmann G; Keiderling W
    Nucl Med (Stuttg); 1967; ():151-6. PubMed ID: 5601730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.